Los Angeles Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,169
| Closed | -$435K | – | 1479 |
|
|
2021
Q4 | $435K | Sell |
5,169
-1,949
| -27% | -$164K | ﹤0.01% | 1072 |
|
|
2021
Q3 | $642K | Hold |
7,118
| – | – | ﹤0.01% | 948 |
|
|
2021
Q2 | $679K | Sell |
7,118
-2,886
| -29% | -$275K | ﹤0.01% | 1028 |
|
|
2021
Q1 | $1.14M | Sell |
10,004
-8,777
| -47% | -$999K | 0.01% | 837 |
|
|
2020
Q4 | $2.6M | Buy |
18,781
+101
| +0.5% | +$14K | 0.01% | 578 |
|
|
2020
Q3 | $1.54M | Buy |
18,680
+3,360
| +22% | +$276K | 0.01% | 656 |
|
|
2020
Q2 | $1.2M | Buy |
15,320
+2,260
| +17% | +$177K | 0.01% | 785 |
|
|
2020
Q1 | $580K | Buy |
+13,060
| New | +$580K | ﹤0.01% | 858 |
|
|
2019
Q4 | – | Sell |
-5,780
| Closed | -$247K | – | 1332 |
|
|
2019
Q3 | $247K | Hold |
5,780
| – | – | ﹤0.01% | 1168 |
|
|
2019
Q2 | $367K | Sell |
5,780
-10,540
| -65% | -$669K | ﹤0.01% | 1124 |
|
|
2019
Q1 | $1.13M | Sell |
16,320
-1,000
| -6% | -$69.4K | 0.01% | 813 |
|
|
2018
Q4 | $753K | Buy |
17,320
+1,515
| +10% | +$65.9K | ﹤0.01% | 836 |
|
|
2018
Q3 | $1.21M | Buy |
15,805
+1,440
| +10% | +$110K | 0.01% | 803 |
|
|
2018
Q2 | $1.1M | Sell |
14,365
-380
| -3% | -$29.2K | 0.01% | 859 |
|
|
2018
Q1 | $752K | Buy |
+14,745
| New | +$752K | ﹤0.01% | 910 |
|